Phospholipid biosynthesis, Phosphatidylinositol-4-phosphate 5-kinase-like
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005886 | plasma membrane | 3 | 1 |
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4ICV0
Term | Name | Level | Count |
---|---|---|---|
GO:0006793 | phosphorus metabolic process | 3 | 12 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016310 | phosphorylation | 5 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006644 | phospholipid metabolic process | 4 | 1 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 1 |
GO:0006661 | phosphatidylinositol biosynthetic process | 6 | 1 |
GO:0008610 | lipid biosynthetic process | 4 | 1 |
GO:0008654 | phospholipid biosynthetic process | 5 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0019637 | organophosphate metabolic process | 3 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 1 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 1 |
GO:0046486 | glycerolipid metabolic process | 4 | 1 |
GO:0046488 | phosphatidylinositol metabolic process | 6 | 1 |
GO:0046854 | phosphatidylinositol phosphate biosynthetic process | 7 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090407 | organophosphate biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005524 | ATP binding | 5 | 12 |
GO:0016301 | kinase activity | 4 | 12 |
GO:0016307 | phosphatidylinositol phosphate kinase activity | 5 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0030554 | adenyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 238 | 240 | PF00675 | 0.397 |
CLV_NRD_NRD_1 | 292 | 294 | PF00675 | 0.384 |
CLV_PCSK_KEX2_1 | 294 | 296 | PF00082 | 0.403 |
CLV_PCSK_KEX2_1 | 333 | 335 | PF00082 | 0.386 |
CLV_PCSK_PC1ET2_1 | 294 | 296 | PF00082 | 0.406 |
CLV_PCSK_PC1ET2_1 | 333 | 335 | PF00082 | 0.386 |
CLV_PCSK_PC7_1 | 290 | 296 | PF00082 | 0.374 |
CLV_PCSK_PC7_1 | 329 | 335 | PF00082 | 0.238 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.473 |
CLV_PCSK_SKI1_1 | 135 | 139 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.432 |
CLV_PCSK_SKI1_1 | 280 | 284 | PF00082 | 0.300 |
CLV_PCSK_SKI1_1 | 358 | 362 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 416 | 420 | PF00082 | 0.309 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.561 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.535 |
CLV_PCSK_SKI1_1 | 97 | 101 | PF00082 | 0.326 |
CLV_Separin_Metazoa | 299 | 303 | PF03568 | 0.335 |
DEG_APCC_DBOX_1 | 149 | 157 | PF00400 | 0.315 |
DEG_SPOP_SBC_1 | 342 | 346 | PF00917 | 0.358 |
DEG_SPOP_SBC_1 | 350 | 354 | PF00917 | 0.288 |
DOC_MAPK_gen_1 | 154 | 163 | PF00069 | 0.277 |
DOC_MAPK_gen_1 | 77 | 85 | PF00069 | 0.576 |
DOC_MAPK_HePTP_8 | 170 | 182 | PF00069 | 0.339 |
DOC_MAPK_MEF2A_6 | 173 | 182 | PF00069 | 0.305 |
DOC_MAPK_MEF2A_6 | 77 | 85 | PF00069 | 0.587 |
DOC_MAPK_NFAT4_5 | 173 | 181 | PF00069 | 0.309 |
DOC_PP1_RVXF_1 | 282 | 288 | PF00149 | 0.283 |
DOC_PP1_RVXF_1 | 414 | 421 | PF00149 | 0.374 |
DOC_PP2B_LxvP_1 | 69 | 72 | PF13499 | 0.537 |
DOC_PP4_FxxP_1 | 286 | 289 | PF00568 | 0.425 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.413 |
DOC_USP7_MATH_1 | 343 | 347 | PF00917 | 0.321 |
DOC_USP7_MATH_1 | 43 | 47 | PF00917 | 0.509 |
DOC_USP7_MATH_1 | 52 | 56 | PF00917 | 0.509 |
DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.320 |
LIG_14-3-3_CanoR_1 | 12 | 19 | PF00244 | 0.585 |
LIG_14-3-3_CanoR_1 | 157 | 162 | PF00244 | 0.375 |
LIG_14-3-3_CanoR_1 | 24 | 31 | PF00244 | 0.490 |
LIG_14-3-3_CanoR_1 | 358 | 363 | PF00244 | 0.442 |
LIG_14-3-3_CanoR_1 | 372 | 381 | PF00244 | 0.316 |
LIG_14-3-3_CanoR_1 | 436 | 441 | PF00244 | 0.424 |
LIG_14-3-3_CanoR_1 | 84 | 92 | PF00244 | 0.506 |
LIG_Actin_WH2_1 | 293 | 310 | PF00022 | 0.374 |
LIG_Actin_WH2_2 | 10 | 26 | PF00022 | 0.528 |
LIG_Actin_WH2_2 | 294 | 310 | PF00022 | 0.374 |
LIG_AP2alpha_1 | 192 | 196 | PF02296 | 0.293 |
LIG_BRCT_BRCA1_1 | 126 | 130 | PF00533 | 0.428 |
LIG_DLG_GKlike_1 | 436 | 443 | PF00625 | 0.425 |
LIG_FHA_1 | 141 | 147 | PF00498 | 0.430 |
LIG_FHA_1 | 158 | 164 | PF00498 | 0.225 |
LIG_FHA_1 | 402 | 408 | PF00498 | 0.442 |
LIG_FHA_1 | 439 | 445 | PF00498 | 0.320 |
LIG_FHA_2 | 274 | 280 | PF00498 | 0.305 |
LIG_FHA_2 | 351 | 357 | PF00498 | 0.374 |
LIG_FHA_2 | 375 | 381 | PF00498 | 0.425 |
LIG_LIR_Apic_2 | 109 | 114 | PF02991 | 0.404 |
LIG_LIR_Apic_2 | 283 | 289 | PF02991 | 0.425 |
LIG_LIR_Gen_1 | 303 | 312 | PF02991 | 0.324 |
LIG_LIR_Gen_1 | 314 | 323 | PF02991 | 0.277 |
LIG_LIR_Gen_1 | 438 | 448 | PF02991 | 0.429 |
LIG_LIR_Gen_1 | 91 | 99 | PF02991 | 0.455 |
LIG_LIR_Nem_3 | 303 | 307 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 314 | 318 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 376 | 381 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 392 | 398 | PF02991 | 0.285 |
LIG_LIR_Nem_3 | 438 | 443 | PF02991 | 0.362 |
LIG_LIR_Nem_3 | 91 | 96 | PF02991 | 0.308 |
LIG_LYPXL_yS_3 | 221 | 224 | PF13949 | 0.335 |
LIG_Pex14_2 | 107 | 111 | PF04695 | 0.375 |
LIG_Pex14_2 | 192 | 196 | PF04695 | 0.307 |
LIG_REV1ctd_RIR_1 | 128 | 137 | PF16727 | 0.315 |
LIG_REV1ctd_RIR_1 | 412 | 420 | PF16727 | 0.362 |
LIG_SH2_CRK | 175 | 179 | PF00017 | 0.425 |
LIG_SH2_CRK | 304 | 308 | PF00017 | 0.343 |
LIG_SH2_CRK | 315 | 319 | PF00017 | 0.253 |
LIG_SH2_PTP2 | 395 | 398 | PF00017 | 0.305 |
LIG_SH2_STAP1 | 159 | 163 | PF00017 | 0.281 |
LIG_SH2_STAP1 | 315 | 319 | PF00017 | 0.313 |
LIG_SH2_STAP1 | 433 | 437 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.335 |
LIG_SH2_STAT5 | 188 | 191 | PF00017 | 0.332 |
LIG_SH2_STAT5 | 395 | 398 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 405 | 408 | PF00017 | 0.305 |
LIG_SH3_3 | 99 | 105 | PF00018 | 0.420 |
LIG_SUMO_SIM_par_1 | 142 | 148 | PF11976 | 0.413 |
LIG_SUMO_SIM_par_1 | 397 | 404 | PF11976 | 0.425 |
LIG_TRAF2_1 | 145 | 148 | PF00917 | 0.390 |
LIG_TYR_ITIM | 219 | 224 | PF00017 | 0.335 |
LIG_TYR_ITIM | 393 | 398 | PF00017 | 0.290 |
LIG_UBA3_1 | 137 | 142 | PF00899 | 0.406 |
LIG_WRC_WIRS_1 | 385 | 390 | PF05994 | 0.374 |
LIG_WRC_WIRS_1 | 437 | 442 | PF05994 | 0.425 |
LIG_WRC_WIRS_1 | 92 | 97 | PF05994 | 0.458 |
MOD_CK2_1 | 109 | 115 | PF00069 | 0.473 |
MOD_CK2_1 | 142 | 148 | PF00069 | 0.346 |
MOD_CK2_1 | 224 | 230 | PF00069 | 0.418 |
MOD_CK2_1 | 350 | 356 | PF00069 | 0.440 |
MOD_CK2_1 | 374 | 380 | PF00069 | 0.446 |
MOD_CK2_1 | 436 | 442 | PF00069 | 0.399 |
MOD_CK2_1 | 47 | 53 | PF00069 | 0.608 |
MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.374 |
MOD_GlcNHglycan | 260 | 263 | PF01048 | 0.402 |
MOD_GlcNHglycan | 345 | 348 | PF01048 | 0.406 |
MOD_GlcNHglycan | 353 | 356 | PF01048 | 0.423 |
MOD_GlcNHglycan | 61 | 66 | PF01048 | 0.459 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.490 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.328 |
MOD_GSK3_1 | 337 | 344 | PF00069 | 0.364 |
MOD_GSK3_1 | 370 | 377 | PF00069 | 0.435 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.615 |
MOD_GSK3_1 | 67 | 74 | PF00069 | 0.561 |
MOD_LATS_1 | 278 | 284 | PF00433 | 0.425 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.305 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.305 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.414 |
MOD_NEK2_1 | 178 | 183 | PF00069 | 0.359 |
MOD_NEK2_1 | 224 | 229 | PF00069 | 0.374 |
MOD_NEK2_1 | 23 | 28 | PF00069 | 0.447 |
MOD_NEK2_1 | 313 | 318 | PF00069 | 0.316 |
MOD_NEK2_1 | 414 | 419 | PF00069 | 0.346 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.626 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.612 |
MOD_PIKK_1 | 124 | 130 | PF00454 | 0.425 |
MOD_PIKK_1 | 250 | 256 | PF00454 | 0.389 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.674 |
MOD_PK_1 | 142 | 148 | PF00069 | 0.413 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.512 |
MOD_PKA_2 | 258 | 264 | PF00069 | 0.452 |
MOD_PKA_2 | 265 | 271 | PF00069 | 0.260 |
MOD_PKA_2 | 371 | 377 | PF00069 | 0.362 |
MOD_PKA_2 | 435 | 441 | PF00069 | 0.338 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.364 |
MOD_Plk_1 | 109 | 115 | PF00069 | 0.457 |
MOD_Plk_1 | 280 | 286 | PF00069 | 0.303 |
MOD_Plk_1 | 313 | 319 | PF00069 | 0.305 |
MOD_Plk_1 | 61 | 67 | PF00069 | 0.480 |
MOD_Plk_2-3 | 109 | 115 | PF00069 | 0.467 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.405 |
MOD_Plk_4 | 166 | 172 | PF00069 | 0.305 |
MOD_Plk_4 | 197 | 203 | PF00069 | 0.420 |
MOD_Plk_4 | 313 | 319 | PF00069 | 0.305 |
MOD_Plk_4 | 414 | 420 | PF00069 | 0.320 |
MOD_SUMO_for_1 | 118 | 121 | PF00179 | 0.372 |
MOD_SUMO_for_1 | 448 | 451 | PF00179 | 0.518 |
MOD_SUMO_for_1 | 58 | 61 | PF00179 | 0.499 |
TRG_DiLeu_BaEn_1 | 148 | 153 | PF01217 | 0.305 |
TRG_DiLeu_BaEn_2 | 90 | 96 | PF01217 | 0.405 |
TRG_DiLeu_BaEn_4 | 185 | 191 | PF01217 | 0.335 |
TRG_ENDOCYTIC_2 | 175 | 178 | PF00928 | 0.390 |
TRG_ENDOCYTIC_2 | 221 | 224 | PF00928 | 0.295 |
TRG_ENDOCYTIC_2 | 304 | 307 | PF00928 | 0.329 |
TRG_ENDOCYTIC_2 | 315 | 318 | PF00928 | 0.275 |
TRG_ENDOCYTIC_2 | 395 | 398 | PF00928 | 0.305 |
TRG_ER_diArg_1 | 293 | 296 | PF00400 | 0.409 |
TRG_NLS_MonoExtC_3 | 292 | 298 | PF00514 | 0.452 |
TRG_NLS_MonoExtN_4 | 290 | 297 | PF00514 | 0.374 |
TRG_Pf-PMV_PEXEL_1 | 294 | 298 | PF00026 | 0.398 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCT9 | Leptomonas seymouri | 23% | 83% |
A0A0N1PE70 | Leptomonas seymouri | 56% | 100% |
A0A0S4IZA7 | Bodo saltans | 25% | 99% |
A0A0S4JRR3 | Bodo saltans | 39% | 98% |
A0A1X0P9B0 | Trypanosomatidae | 48% | 100% |
A0A1X0PB79 | Trypanosomatidae | 22% | 95% |
A0A3R7KQW9 | Trypanosoma rangeli | 45% | 100% |
A0A3S7XA92 | Leishmania donovani | 100% | 100% |
A0A422N247 | Trypanosoma rangeli | 22% | 95% |
A4HNP5 | Leishmania braziliensis | 68% | 100% |
C9ZM20 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 23% | 95% |
D0A2K2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
D3ZSI8 | Rattus norvegicus | 25% | 83% |
E9ASF4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
O13010 | Sus scrofa | 24% | 100% |
O60331 | Homo sapiens | 24% | 68% |
O70161 | Mus musculus | 26% | 69% |
O70172 | Mus musculus | 24% | 100% |
O88377 | Rattus norvegicus | 24% | 100% |
P48426 | Homo sapiens | 24% | 100% |
P70182 | Mus musculus | 24% | 83% |
P78356 | Homo sapiens | 24% | 100% |
Q0P5F7 | Bos taurus | 25% | 100% |
Q4Q241 | Leishmania major | 91% | 100% |
Q5F356 | Gallus gallus | 24% | 100% |
Q5I6B8 | Rattus norvegicus | 25% | 66% |
Q5PQ01 | Xenopus laevis | 26% | 100% |
Q5R488 | Pongo abelii | 26% | 100% |
Q6GL14 | Xenopus tropicalis | 26% | 100% |
Q6IQE1 | Danio rerio | 25% | 100% |
Q80XI4 | Mus musculus | 24% | 100% |
Q8TBX8 | Homo sapiens | 26% | 100% |
Q91XU3 | Mus musculus | 26% | 100% |
Q99755 | Homo sapiens | 25% | 81% |
Q9R0I8 | Rattus norvegicus | 24% | 100% |
V5BA13 | Trypanosoma cruzi | 46% | 100% |
V5BV28 | Trypanosoma cruzi | 22% | 96% |